Skip to content

Clinical trials

Phase 1/2 Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Phase 1/2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20072
20101
20121
20131
20141
20155
20171
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Unknown status3
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imcyse SA2
Novo Cellular Medicine Institute LLP2
Abu Dhabi Stem Cells Center1
Banc de Sang i Teixits1
Cabaletta Bio1
Charite University, Berlin, Germany1
Genesis Limited1
Germans Trias i Pujol Hospital1
Johns Hopkins University1
Mapi Pharma Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting18
Multiple Sclerosis9
Multiple Sclerosis, Chronic Progressive6
Autoimmune Diseases2
Nervous System Diseases2
Demyelinating Diseases1
Inflammation1
Nerve Degeneration1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.